ResMed Inc. (RMD)

228.35USD -0.37% (-0.84)

Over 1M: +8.1%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

210 220 230 240
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q1 '24 — Cost of Revenue: 502.3M Q2 '24 — Cost of Revenue: 515.9M Q3 '24 — Cost of Revenue: 504.2M Q4 '24 — Cost of Revenue: 507.7M Q1 '25 — Cost of Revenue: 507.3M Q2 '25 — Cost of Revenue: 530.8M Q3 '25 — Cost of Revenue: 525.3M Q4 '25 — Cost of Revenue: 527.9M Q1 '26 — Cost of Revenue: 514.8M Q2 '26 — Cost of Revenue: 544.1M Q3 '26 — Cost of Revenue: 540.4M Q4 '26 — Cost of Revenue: 602.4M 0 150M 300M 450M 600M 750M
Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26 Q4 '26
Cost of Revenue

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

7.1
OE margin 27.3%
Oper. margin 33.4%
ROIC 25.8%
Accruals -3.2%
FCF margin 29.2%
OCF margin 31.9%
ROA 17.0%
ROCE 24.9%
ROE 23.1%
Gross margin 61.1%
OCF / EBIT 0.96×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

7.9
EV/EBIT 16.9×
EV/OE 20.7×
FCF yield 5.0%
P/E 21.5×
Div. yield 1.1%
EV/GP 9.3×
P/B 5.0×
P/C 22.3×
EV/Sales 5.7×
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.0
RPO / sales 0.029×
Segment HHI 0.6 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

10.0
ND/EBITDA 0.025
Cash / Debt 2.2×
Debt / Eq 0.1×
Debt payback 0.0 yr
Quick ratio 2.4×
F-score 7.0 pts
Payout 23.0%
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.9
Sales CAGR 4Y +12.1%
Sales/sh Y/Y +10.8%
Shares change -0.87%
Div. growth +12.5%
EBIT CAGR +17.2%
EPS CAGR 4Y +18.4%
EBIT Y/Y +11.9%
EPS Y/Y +9.7%
Sales Q/Q +8.6%
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.